Inhibitory Antibodies
抑制性抗体(Inhibitory Antibodies,常被称为中和抗体或阻断抗体)是一种能够特异性结合目标分子(如受体、酶或细胞因子),并直接抑制或阻断其正常生物学功能的特异性抗体。
| 货号 | 产品 | 反应 | 应用 | 偶联 | 引用 |
|---|---|---|---|---|---|
| BF6250 | Intetumumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6251 | Ieramilimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6252 | BMS-986021 | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6253 | ASK-8007 | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6254 | Plonmarlimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6255 | Zelminemab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6256 | RG-7652 | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6257 | Budigalimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6258 | Ezabenlimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6259 | Revdofilimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6260 | Robatumumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6261 | Solanezumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6262 | Tadocizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6263 | Bepranemab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6264 | Marstacimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6265 | Tilavonemab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6266 | Torudokimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6267 | Mitazalimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6268 | Ruplizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6269 | Vilobelimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6270 | Axatilimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6271 | Anti-CDH17/Cadherin-17 Ab (PTA001_A4) | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6272 | PY314 | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6273 | Epcoritamab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6274 | Foravirumab | Virus | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6275 | Tozorakimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6276 | Necitumumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6277 | Ocrelizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6278 | Ibritumomab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6279 | Coltuximab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6280 | Lodelcizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6281 | Certolizumab pegol | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6282 | Zigakibart | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6283 | Vadastuximab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6284 | Vantictumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6285 | Reslizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6286 | Samrotamab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6287 | Lifastuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6288 | Gontivimab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6289 | Sotrovimab | Virus | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6290 | Tidutamab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6291 | RSM-01 | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6292 | Nimotuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6293 | Cergutuzumab amunaleukin | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6294 | Sotevtamab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6295 | Vopikitug | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6296 | Dacetuzumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6297 | Clazakizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6298 | Olokizumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |
| BF6299 | Sirukumab | Human | FACS, ELISA, Functional assay | Unconjugated | 0 |